Researchers at the University of Michigan School of Nursing and Rogel Cancer Center have received a $2.3 million grant to study oncology nurses’ exposure to hazardous drugs, including identifying ways to reduce exposure. According to Christopher Friese, Ph.D., R.N., AOCN, FAAN, University of Michigan School of Nursing assistant professor and member of U-M’s Rogel Cancer Center and Institute for Healthcare Policy and Innovation, there are significant acute and long-term side effects from hazardous drug exposures in oncology settings, but not enough evidence-based, risk-reduction efforts to protect health care workers.